bpc-157 randomized controlled trial 2025 for ACL recovery: hype vs. science | Adam C. Cady MHS, ATC, CSCS, PA-C posted on the topic Emerging Peptide Therapies in Orthopaedics:
Description
He has suffered repeated calf tears from soccer and multiple reinjuries caused by returning too quickly
PBMCs were allowed to recover for 1 h at 37 C in RPMI medium supplemented with 10% FCS before RNA isolation
BPC-157 drives angiogenesis and growth factor upregulation, building the vascular infrastructure needed for tissue repair
Delivers butyrate and supports its natural production*2,3
Oral 5-Amino-1MQ can face limitations due to variable bioavailability, degradation in the gastrointestinal tract, and first-pass metabolism in the liver
